Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:31 PM
Ignite Modification Date:
2025-12-24 @ 3:31 PM
NCT ID:
NCT02980692
Eligibility Criteria:
Inclusion Criteria:
* Subject has provided written informed consent
* Subject is ≥ 18 years of age at time of Screening
* Subject must be on stable dose of NSAID for ≥ 4 weeks prior to initiation of IMP
* Subject has a negative evaluation for TB within 4 weeks before initiating IMP
* Subject has a diagnosis of PsA (by the Classification of Psoriatic Arthritis \[CASPAR\] criteria) with symptoms present for at least 6 months.
* Subject has ≥ 3 tender and ≥ 3 swollen joints at Screening and Baseline.
Exclusion Criteria:
* Subject has a planned surgical intervention between Baseline and the Week 24 evaluation for a pretreatment condition
* Subject has an active infection or history of infections
* Subject has any concurrent medical condition or uncontrolled, clinically significant systemic disease
* Subject has a known history of infection with hepatitis B, hepatitis C, or human immunodeficiency virus
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02980692
Study Brief:
Protocol Section:
NCT02980692